Company profile
EndoCrine Biotherapeutics company profile
EndoCrine Biotherapeutics develops early-stage diabetes drugs to improve pancreatic cell health and advance stem cell.
Business identity
- Operating status
- Active
- Company type
- For Profit
- Founded
- 2021-01-01
Headquarters
- Headquarters
- Berkeley, California, United States
- Postal code
- 94704
- Country code
- US
- Continent
- North America